APD-514

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameAPD-514
Drug Alias Nametrisialic acid derivatives (Umea University/Adenovir)ME-0322APD-514
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAdenoviridae InfectionsKeratoconjunctivitis, Infectious
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAdenovir Pharma Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAdenoviridae InfectionsKeratoconjunctivitis, Infectious

Other Information

ATC CodeN/A
Related LinksN/A